Default Category
-
Imprimis (B)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCase HBS-717496-EEntrepreneurshipThis case is a supplement to Imprimis (Case A). It describes the company's decision to enter into the pharmaceutical compounding business in 2013-14. Imprimis purchased a compounded ophthalmological medication called Dropless Therapy, which was injected into patients' eyes post-cataract surgery, with the aim of replacing a complex regimen of prescription eye drops. After a successful launch of the compounded medication, Imprimis ran into complica...Starting at €5.74
-
The Rise and Rise (?) of Walmart (A): Battling Kmart
Casadesus-Masanell, Ramon; Van Den Steen, Eric; Elterman, KarenCase HBS-718431-EStrategyThis case, set in 1990, describes the history of Walmart and asks what competitive strategies Kmart might adopt in response to Walmart's success. It discusses the strategy and organization of both companies in terms of HR practices, store location, distribution, information technology, procurement, pricing, and company culture. This (A) case is the first in a multi-part series that goes on to describe the results of Kmart's competition with Walma...Starting at €8.20
-
Walmart Ecommerce (A): Picking up the Pace
Casadesus-Masanell, Ramon; Elterman, KarenCase HBS-720425-EStrategyThis case is an abridged version (part 1 of 2) of "Walmart's Omnichannel Strategy: Revolution or Miscalculation?" HBS Case 720-370. The (A) case discusses Walmart's early forays into online retail, as well as improvements made under Doug McMillon beginning in 2014. The case describes Walmart's physical stores, delivery options, grocery business, online marketplace, and distribution system. It also discusses the ecommerce startup Jet.com, which Wa...Starting at €8.20
-
Walmart Ecommerce (B): Omnichannel Pursuits
Casadesus-Masanell, Ramon; Elterman, KarenCase HBS-720426-EStrategyThis case is an abridged version (part 2 of 2) of "Walmart's Omnichannel Strategy: Revolution or Miscalculation?", HBS Case 720-370. The (B) case describes Walmart's omnichannel strategy in 2018 as it battled Amazon for online retail market share. Walmart aimed to integrate its enormous brick and mortar footprint with its growing ecommerce business, e.g., through merchandise and grocery delivery and order online, pickup in store options. It a...Starting at €5.74
-
Steemit: A New Social Media
Casadesus-Masanell, Ramon; White, Alexander; Elterman, KarenCase HBS-720428-EStrategyThis case discusses the alternative social media site Steemit, including the principles it was founded on in 2016 and the challenges it faced in 2019. Steemit was a blockchain-based platform that aimed to differentiate itself from other social media companies by returning power to its users, rather than centralizing control among company executives. Steemit rewarded its users with cryptocurrency for posting, commenting on, and upvoting content on...Starting at €8.20
-
Imprimis (D)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCase HBS-717498-EEntrepreneurshipThis case is a supplement to Imprimis (Case A), Imprimis (Case B), and Imprimis (Case C). It describes Imprimis's 2015 decision to develop a $1 per pill compounded alternative to Daraprim, the branded drug that had recently undergone an extreme price hike, raising its price to $750/pill. Imprimis also created compounded alternatives to several other branded drugs, and made investments to increase its manufacturing capabilities. The company now ha...Starting at €5.74
-
The Rise and Rise () of Walmart (B): Kmart Declares Bankruptcy
Casadesus-Masanell, Ramon; Elterman, KarenCase HBS-718510-EStrategyThis case follows up on the competition between Kmart and Walmart as discussed in the A case. It summarizes the companies' positions in the early 2000s, and discusses events between 1990 and Kmart's declaration of bankruptcy in 2002. Walmart grew significantly, expanded internationally, and became a leading player in groceries. However, it also faced criticism regarding its wage and labor practices. Meanwhile, Kmart faced an identity crisis, fall...Starting at €5.74
-
Imprimis (A)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCase HBS-717426-EEntrepreneurshipThis case examines the strategic choices and evolving business model of Imprimis Pharmaceuticals from the perspective of CEO Mark Baum. The A case provides a brief history of the company and of the compounding business, outlining the challenges faced by Imprimis in 2013. At the time, Imprimis was in the process of seeking FDA approval for a branded drug called Impracor. This process, already difficult, was further complicated by recent manufactur...Starting at €8.20
-
Imprimis (C)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCase HBS-717497-EEntrepreneurshipThis case is a supplement to Imprimis (Case A) and Imprimis (Case B). Set in 2015, it first describes Imprimis's decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the problem of high drug prices in the United States. Recent, drastic price hikes on pharmaceutical drugs, such as those initiated by Turing Pharmaceuticals under CEO ...Starting at €5.74